2019年1月18日

本周最大的新聞來自威斯康辛州的高科技領域是迄今為止Brookfield-based Fiserv公司(納斯達克:FISV)巨大的220億美元收購第一個數據(NYSE: FDC)。與此同時,這裏有一些你可能已經錯過了標題和事件:——基本代碼籌集了近250000美元的股權融資,根據證券交易委員會的文件。布魯克菲爾德,WI-based啟動,提供銷售分析和預測軟件,在去年二月在股權融資超過736000美元。創始人兼總裁奧黛麗沃爾比此前擔任副總裁在在線服裝零售商BuySeasons庫存規劃和分析。2017年,她提起訴訟解決BuySeasons對其使用的銷售分析和預測軟件被基本代碼商業化,她加入BuySeasons之前開發的,據BizTimes報告。-Promega有望獲得150萬美元的國家稅收抵免在三年內幫助建設計劃270000平方英尺的研發設施在菲奇堡,威斯康辛州經濟發展公司周三宣布。1.9億美元的項目將創造100個就業機會。生命科學公司去年7月破土動工的設施——點擊這裏查看圖片。箭頭製藥(納斯達克:ARWR)消除彼得·裏昂的位置,該公司的副總裁戰略業務計劃,根據文檔提交給SEC。裏昂於2012年加入該公司,在近三年主要業務發展作用,/他LinkedIn的資料。帕薩迪納市的箭頭運行其實驗室在麥迪遜,WI。 In October, the RNA interference drug developer licensed a hepatitis B drug candidate to a subsidiary of Johnson & Johnson (NYSE: JNJ ) in a cash and stock deal valued at $250 million up front . —EnSync (NYSE: ESNC ), a Milwaukee-area maker of energy storage and power control products, said that its stock is in danger of being delisted from the NYSE American stock exchange, which lists small- and mid-cap companies. The exchange notified the company that its shares have been selling for a low price for “a substantial period of time,” and EnSync has until July 7 to turn things around, perhaps by enacting a reverse stock split. The company’s share price has mostly stayed below 50 cents since last summer and has rarely surpassed $1 over the past four years. —Lastly, Xconomy published an analysis of startup exits in Wisconsin over the past five years . We found 33 deals, led by the recently announced $225 million acquisition of Madison-based Propeller Health by San Diego-based medical device giant ResMed (NYSE: RMD ). The general takeaway from the analysis is advocates of the Badger State’s startup scene have reasons to feel encouraged, but there’s a lot of room for improvement. Jeff Engel is Deputy Editor, Tech at Xconomy. Email: jengel@xconomy.com Follow @JeffEngelXcon